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ONLINE EXCLUSIVE
Chronic Stress and Ovarian 
Function in Female Childhood 
Cancer Survivors
Theresa M. Hardy, PhD, RN, Mauricio Garnier-Villarreal, PhD, Jennifer M. Ohlendorf, PhD, RN,  
and Donna O. McCarthy, PhD, RN
A n estimated 1 in 1,000 adults aged younger than 35 years is a survivor of childhood cancer (Blumenfeld, 2012). Because of significant ad-vances in the treatment of pediatric 
cancer, the five-year survival rate exceeds 80% in the 
United States (Phillips et al., 2015). With an increasing 
number of survivors, there has been growing recogni-
tion of the late effects of cancer treatment (Kremer et 
al., 2013). Among these, reproductive dysfunction is a 
major concern for cancer survivors and is highly cor-
related with quality of life in this population (Cherven, 
Mertens, Wasilewski-Masker, Williamson, & Meacham, 
2015; Knopman, Papadopoulos, Grifo, Fino, & Noyes, 
2010; Kondapalli et al., 2014; Letourneau, Chan, & Ros-
en, 2013). Among female childhood cancer survivors 
(CCSs), 6% experience acute ovarian failure, and an-
other 23% experience a significant reduction in ovarian 
function (Salih et al., 2015). 
In clinical practice, post-treatment ovarian func-
tion is assessed using a profile of hormones, including 
follicle-stimulating hormone (FSH) and luteinizing 
hormone (LH), plus the presence or absence of menses. 
However, neither FSH nor menstrual cyclicity post–
cancer treatment are reliable predictors of future 
fertility (Knight et al., 2015). Because risk of infertility 
related to premature ovarian failure is associated with 
the size of the ovarian follicle pool (ovarian reserve), 
a biomarker that more closely reflects the number of 
remaining follicles in the ovary would have significant 
clinical potential. Anti-Müllerian hormone (AMH) is a 
biomarker of the ovarian reserve; plasma levels reflect 
the continuous noncyclic growth of small follicles and, 
therefore, mirror the size of the remaining follicle pool 
(Jeppesen et al., 2013). AMH is prematurely reduced 
in CCSs (Anderson & Wallace, 2013; Charpentier 
et al., 2014; Miyoshi et al., 2013) and may be an early 
marker of significant gonadotoxicity post-treatment 
(Brougham et al., 2012; Lie Fong et al., 2009). Although 
studies have demonstrated the use of pretreatment 
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AMH concentrations to predict risk of post-treatment 
ovarian dysfunction in cancer survivors (Anderson 
& Wallace, 2013; Lunsford, Whelan, McCormick, & 
McLaren, 2014), its predictive value is limited because 
of incomplete knowledge of factors that influence AMH 
concentrations (Abusief, Missmer, Ginsburg, Weeks, & 
Partridge, 2012; van Dorp et al., 2014).
Cancer survivors have high rates of psychological 
stress and hypothalamic–pituitary–adrenal (HPA) 
dysregulation (Oancea et al., 2014; Taylor, Absolom, 
Snowden, & Eiser, 2012; Zeltzer et al., 2009). One 
of the primary regulators of reproductive function 
is the HPA axis. Psychological stress impairs repro-
ductive function by activating the HPA axis, which 
suppresses hypothalamic pituitary gonadal function 
(Kalantaridou et al., 2010; Louis et al., 2011; Lynch, 
Sundaram, Maisog, Sweeney, & Buck Louis, 2014; 
Whirledge & Cidlowski, 2013). Increased HPA activity 
is associated with elevated levels of glucocorticoids, 
such as cortisol. At homeostatic levels, cortisol con-
tributes to steroid biosynthesis and maintenance of 
gonadotropin release; at elevated levels, it suppresses 
gonadotropin-releasing hormone secretion, reduces 
pulsatile LH secretion, and increases rates of follicle 
atresia (Breen & Mellon, 2014; Whirledge & Cidlowski, 
2013). Because higher rates of psychological stress 
and reproductive dysfunction are observed in cancer 
survivors, the purpose of this study was to explore 
relationships among perceived stress, HPA activity, 
and ovarian function in a sample of female CCSs.
Methods
The sample for this exploratory cross-sectional study 
consisted of female CCSs aged from 16 to 35 years, who 
were previously treated for cancer at the Edinburgh 
Children’s Cancer Centre at the Royal Hospital for Sick 
Children in Scotland. The inclusion criteria were female 
patients treated for cancer at the Edinburgh Children’s 
Cancer Centre who were aged younger than 18 years 
at cancer diagnosis, were aged from 16 to 35 years at 
the time of the study visit, were at least one year from 
completing treatment, and signed written informed 
consent. The exclusion criteria were a positive preg-
nancy test, ovarian surgery in the past six months, 
hormonal therapy in the past three months (GnRH 
agonists, recFSH), alcohol or drug abuse/dependence 
according to ICD-10 criteria, or having received an 
investigational drug in the past three months. 
The Marquette University Institutional Review 
Board and the South East Scotland Research Ethics 
Committee approved this study. Data management 
was compliant with the most current guidelines of the 
Health Insurance Portability and Accountability Act of 
1996 and in full conformity with the principles of the 
Declaration of Helsinki, in accordance with the prin-
ciples laid down in the Convention of the Council of 
Europe for the protection of human rights and dignity 
of the human being. Original patient names and hospital 
bar codes were deidentified by using a new, independent 
numbering system for all study-related documentation. 
A link-list was established and kept separate from other 
study documentation. The link-list was only accessible 
to the study investigators and was kept in a locked office 
at the Royal Hospital for Sick Children. 
Instruments
Assessment of ovarian function included serum 
gonadotropin levels (LH and FSH), estradiol (E2), and 
AMH. Serum levels of these hormones are routinely 
measured during the annual follow-up appointment. 
LH, FSH, and E2 levels are measured to screen for 
gonadotropin deficiency and ovarian dysfunction 
post–cancer treatment (Metzger et al., 2013). The 
laboratory results were retrieved from participants’ 
medical records. Serum AMH levels were analyzed 
using the Beckman Coulter AMH Gen II ELISA. The 
AMH Gen II ELISA has a sensitivity of 0.57 pmol/L. 
HPA activity was determined using measures of 
salivary cortisol and hair cortisol. Salivary cortisol has 
been used to measure HPA activity in cancer survivors 
and other populations (Du et al., 2013; Ho, Fong, Chan, 
& Chan, 2013; Sephton et al., 2013). Cortisol secretory 
activity follows a diurnal pattern, with levels peaking 
after awakening and lowest levels before going to bed 
(Kirschbaum & Hellhammer, 1989). Chronic stress 
is associated with alterations in the cortisol awaken-
ing response (Dedovic & Ngiam, 2015; Révész et al., 
2013) and blunting of the morning–evening diurnal 
slope (Garland, Beck, Lipschitz, & Nakamura, 2015; 
Ho et al., 2013; Schrepf et al., 2015). A commercially 
available ELISA kit by Salimetrics® was used for the 
quantification of cortisol in saliva. This cortisol assay 
kit has a lower detection limit of 7 ng/dl. The mean 
intra-assay coefficient is 5.7%, and the mean inter- 
assay coefficient is 10%. 
Chronic stress has also been associated with ele-
vated levels of cortisol in hair (Russell, Koren, Rieder, 
& Van Uum, 2012; Wells et al., 2014). Hair has a pre-
dictable growth rate of 1 cm per month; the most 
proximal 1 cm segment to the scalp approximates 
the past month’s cortisol production, the second 
most proximal segment the month prior to that, 
and so on (Russell et al., 2012). Hair (3 cm) was pro-
cessed for extraction of cortisol in the laboratory of 
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Clemens-Kirschbaum in Dresden, Germany, as pre-
viously described (Kirschbaum, Tietze, Skoluda, & 
Dettenborn, 2009).
Perceived stress was measured using the 
Perceived Stress Scale (PSS-10) (Cohen, Kamarck, 
& Mermelstein, 1983). The PSS-10 is a 10-item self- 
report scale measuring life stress during the past four 
weeks and is the most widely used measure of this 
concept. The PSS-10 was designed for use in com-
munity samples of participants with education as 
low as junior high. Good to excellent reliability has 
been observed with the PSS-10 in varied populations 
(Cohen et al., 1983), with a Cronbach alpha ranging 
from 0.78–0.91 (Lee, 2012). The measure has been 
demonstrated to reliably measure stress appraisal in 
cancer survivors (Golden-Kreutz, Browne, Frierson, 
& Andersen, 2009). 
Data Collection 
Recruitment was conducted by sending letters of 
invitation to female CCSs in long-term follow-up two 
weeks prior to their annual review appointment. After 
providing informed consent, saliva-collecting devices 
and detailed instructions for collection of samples 
were provided to participants at their appointment. 
Participants were instructed not to eat, smoke, con-
sume caffeine, or exercise for 30 minutes prior to 
sample collection (Schrepf et al., 2015). Participants 
provided three timed saliva samples for the analysis of 
salivary cortisol: the first sample was collected before 
going to bed on the night prior to the study visit, the 
second immediately upon awakening the morning of 
their visit before getting out of bed, and the third 30 
minutes after the second sample. Participants were 
instructed to record the time of saliva collection 
on their saliva-collecting devices and to keep the 
saliva samples refrigerated until coming in for their 
study visit to preserve sample integrity. Participants 
brought the three saliva samples to their study visit. 
Samples were stored at the Royal Hospital for Sick 
Children at –20ºC. Within a week of collection, a 
research nurse picked them up and brought them to 
the Queens Medical Research Institute, where they 
were centrifuged and stored at –80ºC. 
During the study visit, participants provided 
demographic information, including age, ethnicity/
race, level of education, marital status, and employ-
ment status. The following clinical information 
was retrieved from participants’ medical records: 
cancer diagnosis, age at cancer diagnosis, chemo-
therapy/radiation received, and age at menarche. 
Participants then completed the PSS-10 (Cohen et al., 
1983). Lastly, participants provided a sample of hair 
for measurement of hair cortisol. A small sample of 
hair, 20 mg (100–150 strands), was taken from the 
vertex posterior of the participant’s scalp using a new 
pair of thinning shears (Hoffman, Karban, Benitez, 
Goodteacher, & Laudenslager, 2014; Van Uum et al., 
2008). Hair length was recorded, and proximal ends 
of the hair samples were marked. Hair samples were 
stored in aluminum foil for protection before process-
ing (Hoffman et al., 2014) and labeled with a unique 
participant study ID. 
Data Analysis and Interpretation
Means and standard deviations for all demographic 
and clinical variables were reported to describe 
the sample and reveal distributional characteris-
tics. Latent growth curve modeling was used to 
define diurnal cortisol change over time (three time 
points). Change processes are determined by com-
bining the underlying pattern of growth (slope) with 
the initial or baseline measurement (intercept). The 
intercept and slope were then incorporated into the 
overall model as independent predictors of ovarian 
function. 
Bayesian structural equation modeling (SEM) was 
used to explore the relationship between perceived 
stress and HPA activity and to explore relationships 
between perceived stress, biomarkers of HPA activity, 
gonadotropin levels, and AMH (see Figure 1). Bayesian 
SEM was selected because it facilitates greater preci-
sion in estimating the posterior distribution of the 
parameters for small samples. The posterior distri-
bution describes the best estimate of the parameters 
FIGURE 1. Bayesian Path Analysis Model
Note. Covariates consist of age, body mass index, age at menarche, 
and age at diagnosis.
Anti-Müllerian hormone
R2 = 0.332
Follicle-stimulating 
hormone
R2 = 0.418
Luteinizing hormone
R2 = 0.392
Estradiol
R2 = 0.000
Diurnal cortisol intercept
Diurnal cortisol slope
Perceived Stress Scale
Hair cortisol
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given the data and the level of uncertainty about the 
respective parameter by the width of it, represented 
by the credible interval (Yuan & MacKinnon, 2009). 
Bayesian SEM also offers the advantage of incorporat-
ing previous knowledge about the model’s parameters 
through the use of priors. The term “prior” is used to 
refer to the expected parameter distribution based on 
theory or previous research. Given the exploratory 
nature of this study, the authors examined the model 
parameters using weakly informed priors. Weakly 
informed priors are not intended to guide the param-
eters, but rather to provide information to delimitate 
the most likely data space for the parameters. The 
authors used a special case of SEM called path anal-
ysis. In path analysis, every variable in the model is 
directly measured or observed (Bryan, Schmiege, 
& Broaddus, 2007). The authors ran path analysis 
models with salivary cortisol intercept and slope, 
PSS-10, hair cortisol, body mass index, age, age at 
diagnosis, and age at menarche as predictors and with 
AMH, E2, FSH, and LH as outcomes.
Data augmentation was used to account for miss-
ing data. Missing data were treated simultaneously as 
a parameter and data, filling any missing data points 
with the most likely value given the posterior distri-
bution (Merkle, 2011). Data analysis was conducted in 
R (Core Team, 2017). Bayesian path analysis was run 
with the blavaan R package (Merkle & Rosseel, 2018), 
which estimates the model with the general Bayesian 
software JAGS (Plummer, 2003). Convergence of 
the Markov chains was determined using the poten-
tial scale reduction factor, also known as univariate 
R-hat (Gelman & Rubin, 1992). Model convergence 
was achieved when R-hat was lower than 1.1 for every 
parameter (Brooks & Gelman, 1998). The model was 
run with three chains, keeping the last 5,000 iterations 
from each chain to build the posterior distributions. 
Results
Twenty-four female CCSs (
—
X age = 21.79 years, 
SD = 5.68) participated in the study. The major-
ity had at least a high school education (n = 15) and 
were unmarried (n = 19) (see Table 1). Childhood 
cancer diagnoses varied considerably and included 
osteosarcoma (n = 1), rhabdomyosarcoma (n = 
5), Wilms tumor (n = 1), optic chiasmal glioma (n = 1), 
non-Hodgkin lymphoma (n = 3), Ewing sarcoma (n = 
2), immature teratoma of the left ovary (n = 1), B-cell 
lymphoma (n = 1), Hodgkin lymphoma (n = 4), right 
temporal lobe pilocytic astrocytoma (n = 1), pilocytic 
astrocytoma of the conus (n = 1), left renal tumor (n = 
1), undifferentiated sarcoma of posterior sacral region 
(n = 1), and acute lymphoblastic leukemia (n = 1). 
Cancer treatments included chemotherapy only (n = 
11), radiation only (n = 1), chemotherapy and radia-
tion (n = 8), or other treatment (n = 4). Mean length 
of treatment was 0.63 years (SD = 1.05). 
Latent Growth Curve 
The average salivary cortisol intercept (correspond-
ing to the night time point) was 105.25 ng/dl, with a 
variance of 48.53 ng/dl. On average, salivary cortisol 
levels increased 24.19 ng/dl per hour with a variance of 
9.41 ng/dl. The latent growth curve demonstrated het-
erogeneity of variance over time (see Figure 2), with 
increased variability observed at the later time points. 
Some slopes were positive and others flat, creating an 
overdispersion at the later time points. 
TABLE 1. Clinical and Demographic Descriptive Statistics
Variable N Range
—
X SD
Age (years) 24 17–34 21.79 5.68
Age at diagnosis (years) 24 1–16 10.38 5.22
Age at menarche (years) 22 10–15 12.27 1.19
Body mass index (kg/m2) 20 19.96–34.38 24.57 3.81
Perceived Stress Scale total 23 6–32 16.43 6.73
Night cortisol (ng/dl) 20 18.92–262.66 105.26 74.68
Morning cortisol (ng/dl) 21 32.63–644.01 318.74 203.46
Morning cortisol plus 30 minutes (ng/dl) 21 26.24–850.89 392.93 263.68
Hair cortisol (pg/mg) 24 1.08–211.7 19.94 43.23
Follicle-stimulating hormone (U/L) 24 0.7–9.8 4.93 2.34
Luteinizing hormone (U/L) 24 0.5–10.7 4.53 3.12
Estradiol (pmol/L) 24 50–685 197.88 175.04
Anti-Müllerian hormone (pmol/L) 23 2.4–79.5 23.28 17.94
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Bayesian Structural Equation Modeling 
The authors found that the model predictors (i.e., 
salivary cortisol intercept, salivary cortisol slope, hair 
cortisol, and PSS-10) explained 42% of the variance of 
FSH, 39% of LH, 33% of AMH, and 0% of E2. The stan-
dardized regression coefficients allowed the authors 
to compare the effect of different predictors for each 
outcome. For AMH, age, age at diagnosis, perceived 
stress, and hair cortisol levels were the strongest pre-
dictors. For FSH, perceived stress was the strongest 
predictor, followed by the intercept of salivary corti-
sol and age at menarche. For LH, the authors found 
that the three predictors related to cortisol (i.e., sal-
ivary cortisol intercept, salivary cortisol slope, and 
hair cortisol) and age at diagnosis were the strongest 
predictors. For E2, all predictors were equivalent 
around 0, demonstrating that these predictors did not 
characterize the behavior of E2.
Discussion
In this small sample of female CCSs, the mean PSS-10 
score was 16.43 (SD = 6.73), which is higher than the 
mean threshold for stress in the general population 
(13.7 for women) (Cohen et al., 1983). Surviving a 
life-threatening illness, such as pediatric cancer, 
represents a major early life stressor (Laufer et al., 
2012). Several studies have demonstrated that CCSs 
report higher levels of stress than healthy controls 
(Brown, Madan-Swain, & Lambert, 2003; Oancea et 
al., 2014). Keir, Swartz, and Friedman (2007) demon-
strated that long-term cancer survivors are just as 
likely as patients with cancer to report high levels of 
stress, suggesting that the time since diagnosis and 
treatment does not mitigate the psychological stress 
experienced by cancer survivors. 
The authors observed higher mean night salivary 
cortisol concentrations (greater than 100 ng/dl) and 
flattened diurnal cortisol slopes in the current sample 
of female CCSs. In healthy individuals, cortisol concen-
trations peak in the morning about 30 minutes after 
awakening and decline throughout the day (Bergen et 
al., 2012). Higher nighttime cortisol levels and blunted 
cortisol slopes are abnormal diurnal patterns. It is 
hypothesized that these abnormal diurnal patterns 
induce systemic inflammation, which is associated 
with increased incidence of adverse long-term health 
outcomes for cancer survivors (e.g., cancer recurrence, 
chronic symptom experience) (Schrepf et al., 2015). 
To the authors’ knowledge, no studies have exam-
ined hair cortisol levels in CCSs. In this small sample 
of 24 CCSs, the authors found a wide range of three-
month hair cortisol concentrations (range = 1.08–211.7 
pg/mg, 
 —
X = 19.94 pg/mg, SD = 43.23 pg/mg). There was 
one outlier in the sample (211.7 pg/mg); excluding 
the outlier, the range of hair cortisol concentrations 
was 1.08 pg/mg to 55.71 pg/mg. Age may contribute 
to changes in hair cortisol concentrations (Gow, 
Thomson, Rieder, Van Uum, & Koren, 2010); however, 
no association between age and cortisol concentra-
tions was observed in the current sample. The mean 
hair cortisol concentration observed in this sample 
is lower than the mean reported in healthy samples 
(Stalder & Kirschbaum, 2012). In a meta-analysis of 
chronic stress and HPA activity, Miller, Chen, and 
Zhou (2007) reported that patterns of HPA activity 
in response to chronic stress vary by time since onset. 
When the eliciting stimulus of a chronic stressor first 
begins, there is an initial activation of the HPA axis, 
which results in elevated concentrations of corti-
sol. As time passes, this activity lessens, and cortisol 
secretion rebounds to below normal (Miller et al., 
2007). This may explain the lower mean hair corti-
sol concentrations observed in this sample of CCSs. 
Because hypocortisolism and hypercortisolism are 
associated with adverse health outcomes, the find-
ing of lower mean hair cortisol concentrations in this 
sample is notable and requires further investigation 
(Miller et al., 2007). 
FIGURE 2. Diurnal Cortisol Slopes at Three 
Time Points
0—night time; 1—awakening; 2—awakening plus 30 minutes
Note. Each line corresponds to a different participant.
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In this study of 24 CCSs, the authors found that 
the model predictors explained 33% of the variation 
in AMH levels, with the highest standardized regres-
sion coefficients observed for age, age at diagnosis, 
perceived stress, and hair cortisol (see Table 2). AMH 
was inversely associated with age, age at diagnosis, 
and perceived stress; with an increase of one standard 
deviation in age, age at diagnosis, and perceived stress 
score, AMH declined 5.66 pmol/L, 5.19 pmol/L, and 
5.02 pmol/L, respectively. The inverse association 
between age and AMH is well established in the liter-
ature (Kelsey, Wright, Nelson, Anderson, & Wallace, 
2011). Barton et al. (2013) also found that older age at 
diagnosis increased risk of post-treatment infertility 
TABLE 2. Bayesian Path Analysis by Outcome
Predictor b 95% CI Standardized Estimate
Anti-Müllerian hormone
Salivary cortisol intercept 4.138 [–10.39, 18.81] 0.133
Salivary cortisol slope 5.26 [–7.14, 18.28] 0.082
Perceived Stress Scale –5.02 [–10.93, 1.58] –0.287a
Hair cortisol 3.757 [–2.43, 10.57] 0.214a
Body mass index 1.955 [–4.65, 8.29] 0.112
Age –5.664 [–12.37, 1.18] –0.312a
Age at diagnosis –5.187 [–11.86, 1.86] –0.289a
Age at menarche 2.996 [–3.77, 9.32] 0.172
Follicle-stimulating hormone
Salivary cortisol intercept 1.04 [–6.31, 8.45] 0.233a
Salivary cortisol slope 0.286 [–5.6, 6.61] 0.031
Perceived Stress Scale –1.332 [–2.47, –0.05] –0.53a
Hair cortisol 0.381 [–0.93, 1.65] 0.151
Body mass index 0.294 [–0.99, 1.54] 0.117
Age 0.153 [–1.22, 1.51] 0.058
Age at diagnosis 0.113 [–1.32, 1.52] 0.044
Age at menarche 0.571 [–0.77, 1.7] 0.228a
Luteinizing hormone
Salivary cortisol intercept 2.259 [–8.73, 13.95] 0.387a
Salivary cortisol slope 2.802 [–7.85, 10.18] 0.233a
Perceived Stress Scale –0.537 [–2.08, 1.04] –0.164
Hair cortisol 0.814 [–0.88, 2.87] 0.247a
Body mass index –0.384 [–2.4, 1.65] –0.117
Age –0.43 [–2.48, 1.46] –0.126
Age at diagnosis 0.857 [–1.34, 2.87] 0.254a
Age at menarche –0.091 [–1.67, 1.55] –0.028
Estradiol 
Salivary cortisol intercept 0.14 [–13.51, 14.35] 0.00
Salivary cortisol slope 1.065 [–13.37, 14.36] 0.001
Perceived Stress Scale 0.749 [–12.59, 14.75] 0.003
Hair cortisol –0.535 [–14.05, 13.34] –0.002
Body mass index 0.589 [–13.15, 13.94] 0.002
Age –0.1 [–14.03, 13.36] –0.00
Age at diagnosis –0.96 [–14.56, 12.92] –0.004
Age at menarche –1.115 [–14.54, 12.86] –0.005
a Predictors with the highest standardized regression coefficients
CI—confidence interval
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in CCSs, but only in unadjusted models (Barton et al., 
2013). The association among perceived stress, HPA 
activity, and the ovarian reserve has not been examined 
in CCSs. However, Pal, Bevilacqua, and Santoro (2010) 
examined the association between AMH levels and 
chronic psychosocial stress in 89 premenopausal infer-
tile women. The study found that women with chronic 
stress demonstrated significantly lower AMH levels (p = 
0.034) and were three times more likely to be diag-
nosed with diminished ovarian reserve (p = 0.025). Pal 
et al. (2010) concluded that chronic psychosocial stress 
was associated with diminished ovarian reserve. The 
study proposed HPA dysregulation as a plausible expla-
nation for this association; because a biomarker of 
chronic stress was not included in the study, the study 
was unable to provide evidence supporting this theory. 
In the current study, the authors found that, with 
an increase of one standard deviation in hair cortisol 
concentrations, AMH increased 3.76 pmol/L. Although 
the standardized regression coefficients of the diurnal 
cortisol intercept and slope were lower, they were also 
positively associated with AMH levels. Taken together 
(positive associations among hair cortisol concentra-
tions, diurnal cortisol intercept and slope, and AMH 
levels), these findings suggest a positive association 
between cortisol concentrations and the ovarian 
reserve, and support the hypothesis that threshold 
glucocorticoid levels are necessary to sustain ovarian 
function (Whirledge & Cidlowski, 2013). As stated 
previously, the authors found lower mean hair cortisol 
concentrations in the current sample than reported in 
healthy populations (Stalder & Kirschbaum, 2012). 
More than half of the participants in the sample 
exhibited flattened diurnal cortisol slopes. Lower daily 
cortisol output and flattened diurnal cortisol slopes 
have been observed in cancer survivors. These findings 
are consistent with prior studies linking hypocorti-
solism to increased risk of experiencing late effects of 
cancer treatment (Bower et al., 2005; Cuneo et al., 2017; 
Ho et al., 2013; Schrepf et al., 2015; Sephton et al., 2013).
In this study, the authors found that the model pre-
dictors explained 42% of the variation in FSH levels, 
with the highest standardized regression coefficients 
observed for salivary cortisol intercept, perceived 
stress, and age at menarche. The model predictors ex-
plained 39% of the variation in LH levels, with the high-
est standardized regression coefficients observed for 
salivary cortisol intercept and slope, hair cortisol, and 
age at diagnosis. The authors also found that perceived 
stress was inversely associated with FSH and LH levels. 
Because the authors were unable to time the col-
lection of reproductive hormone levels according to 
menstrual cycle phase, a strong association among 
perceived stress and FSH and LH levels was not 
anticipated. Several possible explanations exist for 
the strong inverse association the authors observed 
irrespective of menstrual cycle phase. It may be that 
perceived stress has a significant effect on ovarian 
function regardless of menstrual cycle phase (Schliep 
et al., 2015). Another explanation may be that stress 
perception varies across the menstrual cycle, such 
that the degree to which a woman perceives her life 
to be stressful is, in part, influenced by fluctuations 
in gonadotropin levels (Duchesne & Pruessner, 2013). 
Although perceived stress was inversely associ-
ated with FSH and LH, the authors found that HPA 
activity (hair cortisol, salivary cortisol intercept, and 
salivary cortisol slope) was positively associated with 
FSH and LH levels. The findings support the role 
of glucocorticoids in regulating the hypothalamic– 
pituitary–gonadal axis (Whirledge & Cidlowski, 
2013). Another explanation is that cortisol levels may 
fluctuate across the menstrual cycle, as has been sug-
gested by other studies (Kirschbaum, Kudielka, Gaab, 
Schommer, & Hellhammer, 1999; Nepomnaschy et 
al., 2011; Stephens, Mahon, McCaul, & Wand, 2016; 
Wolfram, Bellingrath, & Kudielka, 2011). Although 
preliminary, the findings from this small sample 
support an association among perceived stress, HPA 
activity, and gonadotropin levels in female CCSs. 
More research is needed to clarify the mechanism 
behind this association and to determine whether 
it varies depending on the temporal nature of the 
stressor and menstrual cycle phase.
Limitations
This exploratory study has several limitations. Because 
of the small sample, the authors were unable to adjust 
for hormonal contraceptive use in the overall model. 
Hormonal contraceptive use is associated with sup-
pression of FSH and LH levels, as well as increased 
production of corticosteroid-binding globulin and 
subsequent decreases in unbound cortisol levels 
KNOWLEDGE TRANSLATION 
 ɐ Perceived stress should be assessed in female childhood cancer 
survivors (CCSs) who report reproductive issues.
 ɐ Hair cortisol may provide a convenient, noninvasive means of 
assessing hypothalamic–pituitary–adrenal activity in CCSs. 
 ɐ Providers should consider factors other than diagnosis and 
treatment-related variables when counseling CCSs regarding their 
future fertility. 
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(Stephens et al., 2016). Further research with larger 
sample sizes is needed to control for the effects of con-
traceptive use on ovarian function and HPA activity in 
female CCSs. In addition, because of the wide variety 
of pediatric cancer diagnoses in this small sample, the 
authors could not adjust for cancer diagnosis- and 
treatment-related factors in the model. Several stud-
ies have found a significant effect of diagnosis- and 
treatment-related factors on post-treatment ovar-
ian function, including the cancer pathology itself 
(van Dorp et al., 2014), the therapeutic regimen 
(Charpentier et al., 2014), and the length of exposure 
(El-Shalakany, Ali, Abdelmaksoud, Abd El-Ghany, & 
Hasan, 2013; Reinmuth et al., 2013). Another limita-
tion is that, because of the great distance that many 
of the participants needed to travel, the authors were 
unable to time study visits to coincide with a specific 
menstrual cycle phase. For this reason, the authors 
were unable to adjust gonadotropin and reproductive 
hormone levels to account for menstrual cycle phase. 
Lastly, the study design was cross-sectional and relied 
on a convenience sample. The study’s findings require 
validation in larger longitudinal studies.
Implications for Nursing 
Reproductive dysfunction is a major concern for 
cancer survivors and is highly correlated with qual-
ity of life in this vulnerable population (Cherven et 
al., 2015; Knopman et al., 2010; Kondapalli et al., 
2014; Letourneau et al., 2013). However, studies 
have demonstrated that cancer survivors are about 
half as likely to be treated for infertility as their sib-
lings (Barton et al., 2013). Although the reasons for 
this discrepancy are not fully understood, healthcare 
providers may perceive fertility treatments to be less 
successful in this population. The guidelines from the 
American Society for Clinical Oncology recommend 
that options for fertility preservation be discussed 
with patients with cancer at the earliest opportunity 
(Knight et al., 2015; Letourneau et al., 2013). Oncology 
nurses play an important role in advocating for cancer 
survivors, helping to initiate conversations regarding 
future fertility as early as possible, and discussing 
factors that may mitigate the risk for post-treatment 
reproductive dysfunction. The findings from this 
study suggest that there may be modifiable factors, 
such as chronic stress, that contribute to risk for 
infertility post-treatment. Oncology nurses can mini-
mize the potential burden of late effects by educating 
patients regarding their risk and what actions can be 
taken prior to or after treatment to reduce this risk 
(McClellan et al., 2013). 
Conclusion
In this exploratory study, the authors sought to exam-
ine the association between chronic stress and ovarian 
function in survivors of childhood cancer. Although 
there is prior evidence suggesting stress affects gonad-
otropin hormone levels, the effects of chronic stress on 
the ovarian reserve and its biomarker AMH are poorly 
understood. The findings from this study provide pre-
liminary evidence to suggest that perceived stress is 
negatively associated with ovarian function and that 
biomarkers of HPA activity are positively associated 
with ovarian function in female CCSs. Few studies have 
examined predictors of the ovarian reserve in CCSs 
apart from diagnosis- and treatment-related factors. 
The findings from this study provide the foundation for 
further research examining the risk for post-treatment 
reproductive dysfunction in female CCSs. 
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